Clinical Trial Update: Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of leflunomide and vemurafenib in patients with V600-mutant metastatic melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Leflunomide (Leflunomide)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Melanoma | Phase 1 | Status: TERMINATED